Loading...
Understanding barriers to the introduction of precision medicines in non-small cell lung cancer: A qualitative interview protocol
Background: While precision medicines targeting genetic mutations and alterations in non-small cell lung cancer (NSCLC) have been available since 2010, their adoption into clinical practice has been slow. Evidence suggests that a number of barriers, such as insufficient clinician knowledge, a need f...
Saved in:
| Published in: | Wellcome Open Res |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
F1000 Research Limited
2018
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5934686/ https://ncbi.nlm.nih.gov/pubmed/29780892 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12688/wellcomeopenres.13976.1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|